Literature DB >> 6268663

Effects of beta-lipotropin and beta-lipotropin-derived peptides on aldosterone production in the rat adrenal gland.

H Matsuoka, P J Mulrow, R Franco-Saenz, C H Li.   

Abstract

To investigate the role of non-ACTH pituitary peptides on steroidogenesis, we studied the effects of synthetic beta-lipotropin, beta-melanotropin, and beta-endorphin on aldosterone and corticosterone stimulation using rat adrenal collagenase-dispersed capsular and decapsular cells. beta-lipotropin induced a significant aldosterone stimulation in a dose-dependent fashion (10 nM-1 muM). beta-endorphin, which is the carboxyterminal fragment of beta-lipotropin, did not stimulate aldosterone production at the doses used (3 nM-6 muM). beta-melanotropin, which is the middle fragment of beta-lipotropin, showed comparable effects on aldosterone stimulation. beta-lipotropin and beta-melanotropin did not affect corticosterone production in decapsular cells. Although ACTH(1-24) caused a significant increase in cyclic AMP production in capsular cells in a dose-dependent fashion (1 nM-1 muM), beta-lipotropin and beta-melanotropin did not induce an increase in cyclic AMP production at the doses used (1 nM-1 muM). The beta-melanotropin analogue (glycine[Gly](10)-beta-melanotropin) inhibited aldosterone production induced by beta-lipotropin or beta-melanotropin, but did not inhibit aldosterone production induced by ACTH(1-24) or angiotensin II. Corticotropin-inhibiting peptide (ACTH(7-38)) inhibited not only ACTH(1-24) action but also beta-lipotropin or beta-melanotropin action; however it did not affect angiotensin II-induced aldosterone production. (saralasin [Sar](1); alanine [Ala](8))-Angiotensin II inhibited the actions of beta-lipotropin and beta-melanotropin as well as angiotensin II. These results indicate that (a) beta-lipotropin and beta-melanotropin cause a significant stimulation of aldosterone production in capsular cells, (b) beta-lipotropin and beta-melanotropin have a preferential effect on zona glomerulosa cells, (c) beta-melanotropin contains the active peptide core necessary for aldosterone stimulation, (d) the effects of these peptides on aldosterone production may be independent of cyclic AMP, and (e) the receptors for beta-lipotropin or beta-melanotropin may be different from those for ACTH or angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268663      PMCID: PMC370857          DOI: 10.1172/jci110311

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

Review 2.  The evolution of vertebrate corticotrophin and melanocyte stimulating hormone.

Authors:  P J Lowry; A P Scott
Journal:  Gen Comp Endocrinol       Date:  1975-05       Impact factor: 2.822

3.  Fat cell adenylate cyclase activation by sheep -lipotropic hormone.

Authors:  M Lis; C Gilardeau; M Chrétien
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

4.  Normal and abnormal regulation of beta-msh in man.

Authors:  K Abe; W E Nicholson; G W Liddle; D N Orth; D P Island
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

5.  Control of aldosterone secretion by the pituitary gland.

Authors:  W P Palmore; P J Mulrow
Journal:  Science       Date:  1967-12-15       Impact factor: 47.728

6.  Biological proprtie of ovine beta-lipotropic hormone.

Authors:  P Lohmar; C H Li
Journal:  Endocrinology       Date:  1968-05       Impact factor: 4.736

7.  Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins.

Authors:  J J Gilkes; G A Bloomfield; A P Scott; P J Lowry; J G Ratcliffe; J Landon; L H Rees
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

8.  Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.

Authors:  W W Davis; H H Newsome; L D Wright; W G Hammond; J Easton; F C Bartter
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

9.  Plasma levels of beta-MSH and ACTH during acute stresses and metyrapone administration in man.

Authors:  Y Hirata; N Sakamoto; S Matsukura; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

10.  Steroidogenesis and extracellular cAMP accumulation in adrenal tumor cell cultures.

Authors:  B P Schimmer; A E Zimmerman
Journal:  Mol Cell Endocrinol       Date:  1976-03       Impact factor: 4.102

View more
  5 in total

1.  A possible role for intermediate lobe peptides in the pathogenesis of idiopathic aldosteronism.

Authors:  P J Mulrow
Journal:  Trans Am Clin Climatol Assoc       Date:  1984

2.  Beta endorphin selectively stimulates aldosterone secretion in hypophysectomized, nephrectomized dogs.

Authors:  H G Güllner; J R Gill
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

3.  Release of beta-lipotropin- and beta-endorphin-like material induced by angiotensin in the conscious rat.

Authors:  U Beuers; G Hertting; W Knepel
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

4.  Central serotonergic stimulation of aldosterone secretion.

Authors:  Y Shenker; M D Gross; R J Grekin
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 5.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.